Page 6 - Biotechnology Vector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

According to Anna Popova, EpiVacCorona produces "quite strong and effective immunity" but works "rather slowly"

Anna Popova said that the antibodies neutralize both the common strain and the British one

MOSCOW, March 5. /TASS/. Mass inoculation with the EpiVacCorona vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector will begin in the second half of March, the center’s Director General Rinat Maksyutov told Vesti news show on Rossiya 1 Friday. "Our fellow citizens will be able to get vaccinated [with EpiVacCorona] starting in the second half of March," he said. In October 2020, EpiVacCorona became the second coronavirus vaccine registered in Russia. The vaccine consists of artificially synthesized short fragments of viral proteins - peptides - that m...

To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Po...